Xenogeneic Graft-versus-Host-Disease in NOD-scid IL-2Rγnull Mice Display a T-Effector Memory Phenotype

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Ali, Niwa ^a   Flutter, Barry ^a   Sanchez Rodriguez, Robert ^a,b   Sharif Paghaleh, Ehsan ^a   Barber, Linda D ^a   Lombardi, Giovanna ^a   Nestle, Frank O ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD45 ANTIGEN; CUTANEOUS LYMPHOCYTE ASSOCIATED ANTIGEN; INTERLEUKIN 2 RECEPTOR GAMMA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BLOOD CELL; BONE MARROW CELL; CD3+ T LYMPHOCYTE; CONTROLLED STUDY; EFFECTOR CELL; ENGRAFTMENT; FEMALE; GENE DELETION; GRAFT VERSUS HOST REACTION; HOST CELL; IMMUNOLOGICAL MEMORY; LYMPH NODE CELL; LYMPHOCYTE HOMING; MALE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; SCID MOUSE; SPLEEN CELL; STRAIN DIFFERENCE; T LYMPHOCYTE SUBPOPULATION; XENOGRAFT;

ANIMALS; FEMALE; GRAFT VS HOST DISEASE; HUMANS; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; PHENOTYPE; SEVERE COMBINED IMMUNODEFICIENCY; SKIN; T-LYMPHOCYTES;

MUS;

EID: 84865514740     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044219     Document Type: Article

References (36)

1. Lee SJ, (2005) New approaches for preventing and treating chronic graft-versus-host disease. Blood 105: 4200-4206.
2. Champlin R, Ho W, Gajewski J, Feig S, Burnison M, et al. (1990) Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation. Blood 76: 418-423.
3. Gallardo D, Garcia-Lopez J, Sureda A, Canals C, Ferra C, et al. (1997) Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase. Bone Marrow Transplant 20: 945-952.
4. Shultz LD, Ishikawa F, Greiner DL, (2007) Humanized mice in translational biomedical research. Nat Rev Immunol 7: 118-130.
5. Shultz LD, Brehm MA, Bavari S, Greiner DL, (2011) Humanized mice as a preclinical tool for infectious disease and biomedical research. Ann N Y Acad Sci 1245: 50-54.
6. van Rijn RS, Simonetti ER, Hagenbeek A, Hogenes MC, de Weger RA, et al. (2003) A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/- gammac-/- double-mutant mice. Blood 102: 2522-2531.
7. Chu CC, Ali N, Karagiannis P, Di Meglio P, Skowera A, et al. (2012) Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation. J Exp Med.
8. Carroll RG, Carpenito C, Shan X, Danet-Desnoyers G, Liu R, et al. (2008) Distinct effects of IL-18 on the engraftment and function of human effector CD8 T cells and regulatory T cells. PLoS One 3: e3289.
9. Mutis T, van Rijn RS, Simonetti ER, Aarts-Riemens T, Emmelot ME, et al. (2006) Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-/-gammac-/- immunodeficient mice. Clin Cancer Res 12: 5520-5525.
10. van Rijn RS, Simonetti ER, Hagenbeek A, Bonyhadi M, Storm G, et al. (2007) Quantitative assessment of human T lymphocytes in RAG2(-/-)gammac(-/-) mice: the impact of ex vivo manipulation on in vivo functionality. Exp Hematol 35: 117-127.
11. King MA, Covassin L, Brehm MA, Racki W, Pearson T, et al. (2009) Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex. Clin Exp Immunol 157: 104-118.
12. Gregoire-Gauthier J, Durrieu L, Duval A, Fontaine F, Dieng MM, et al. (2012) Use of immunoglobulins in the prevention of GvHD in a xenogeneic NOD/SCID/gammac- mouse model. Bone Marrow Transplant 47: 439-450.
13. Reddy P, Ferrara JL, (2003) Immunobiology of acute graft-versus-host disease. Blood Rev 17: 187-194.
14. Tsuchiyama J, Yoshino T, Saito T, Furukawa T, Ito K, et al. (2009) Cutaneous lymphocyte antigen-positive T cells may predict the development of acute GVHD: alterations and differences of CLA+ T- and NK-cell fractions. Bone Marrow Transplant 43: 863-873.
15. Engelhardt BG, Jagasia M, Savani BN, Bratcher NL, Greer JP, et al. (2011) Regulatory T cell expression of CLA or alpha(4)beta(7) and skin or gut acute GVHD outcomes. Bone Marrow Transplant 46: 436-442.
16. Greiner DL, Shultz LD, Yates J, Appel MC, Perdrizet G, et al. (1995) Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice. Am J Pathol 146: 888-902.
17. King M, Pearson T, Shultz LD, Leif J, Bottino R, et al. (2007) Development of new-generation HU-PBMC-NOD/SCID mice to study human islet alloreactivity. Ann N Y Acad Sci 1103: 90-93.
18. King M, Pearson T, Shultz LD, Leif J, Bottino R, et al. (2008) A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene. Clin Immunol 126: 303-314.
19. Sagoo P, Ali N, Garg G, Nestle FO, Lechler RI, et al. (2011) Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells. Sci Transl Med 3: 83ra42.
20. Wagar EJ, Cromwell MA, Shultz LD, Woda BA, Sullivan JL, et al. (2000) Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice. J Immunol 165: 518-527.
21. Matthews K, Lim Z, Afzali B, Pearce L, Abdallah A, et al. (2009) Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab. Haematologica 94: 956-966.
22. Ito R, Katano I, Kawai K, Hirata H, Ogura T, et al. (2009) Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice. Transplantation 87: 1654-1658.
23. Nervi B, Rettig MP, Ritchey JK, Wang HL, Bauer G, et al. (2007) Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice. Exp Hematol 35: 1823-1838.
24. Vlad G, Stokes MB, Liu Z, Chang CC, Sondermeijer H, et al. (2009) Suppression of xenogeneic graft-versus-host disease by treatment with immunoglobulin-like transcript 3-Fc. Hum Immunol 70: 663-669.
25. Ferrara JL, Deeg HJ, (1991) Graft-versus-host disease. N Engl J Med 324: 667-674.
26. Picker LJ, Treer JR, Ferguson-Darnell B, Collins PA, Bergstresser PR, et al. (1993) Control of lymphocyte recirculation in man. II. Differential regulation of the cutaneous lymphocyte-associated antigen, a tissue-selective homing receptor for skin-homing T cells. J Immunol 150: 1122-1136.
27. Fuhlbrigge RC, Kieffer JD, Armerding D, Kupper TS, (1997) Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature 389: 978-981.
28. Berg EL, Yoshino T, Rott LS, Robinson MK, Warnock RA, et al. (1991) The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1. J Exp Med 174: 1461-1466.
29. Leung DY, Gately M, Trumble A, Ferguson-Darnell B, Schlievert PM, et al. (1995) Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production. J Exp Med 181: 747-753.
30. Kupper TS, Fuhlbrigge RC, (2004) Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol 4: 211-222.
31. Hoffmann-Fezer G, Gall C, Zengerle U, Kranz B, Thierfelder S, (1993) Immunohistology and immunocytology of human T-cell chimerism and graft-versus-host disease in SCID mice. Blood 81: 3440-3448.
32. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A, (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
33. Sallusto F, Mackay CR, Lanzavecchia A, (2000) The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 18: 593-620.
34. Sallusto F, Geginat J, Lanzavecchia A, (2004) Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 22: 745-763.
35. Zheng H, Matte-Martone C, Jain D, McNiff J, Shlomchik WD, (2009) Central memory CD8+ T cells induce graft-versus-host disease and mediate graft-versus-leukemia. J Immunol 182: 5938-5948.
36. Chen BJ, Deoliveira D, Cui X, Le NT, Son J, et al. (2007) Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse. Blood 109: 3115-3123.